Clinical Trial

Multicenter Mpact DM France

Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of the study is to evaluate the 10-year performance of the MPACT DM cup in the treatment of patients requiring total hip arthroplasty. The primary endpoint is the 10-year life span of the prosthesis according to the Kaplan Meier curve.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-04-18.
Trial Details
NCT Number NCT05818891
Lead Sponsor Medacta International SA
Conditions Total Hip Arthroplasty, Survival, Prosthesis
Enrollment 600 participants
Start Date 2018-04-05
Primary Completion 2028-04 (estimated)
Study Completion 2031-04 (estimated)
Updated on ClinicalTrials.gov 2025-09-29